Covariate-Adaptive Sample Size Re-estimation for Population-Standardized Historical Control Designs in Single-Arm Trials
单臂试验总体标准化历史对照设计的协变量自适应样本量重估AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要以实际入组人群的标准化治疗效应为目标,并处理外部历史对照的基线不平衡。
单臂试验总体标准化历史对照设计的协变量自适应样本量重估AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Externally controlled single-arm trials are increasingly considered when randomized controls are infeasible, but baseline imbalance between the active-arm trial and historical controls complicates both estimation and sample size planning. We propose a population-standardized design framework in which the target estimand is defined for the actually enrolled active-arm population and historical-control outcomes are standardized to that population through a pre-specified balancing score. Building on this estimand, we develop an outcome-blinded, covariate-adaptive sample size re-estimation (SSR) procedure that updates the required sample size using only accumulating baseline covariates, without using active-arm outcomes during enrollment. The method combines an initial scenario-based design with sequential updates of the enrolled-population score distribution, standardized control parameters, and target sample size under pre-specified stopping rules. We give conditional and unconditional power interpretations and sufficient conditions for approximate type I error control under repeated blinded SSR. In simulation studies with distributional shifts between planned and true active-arm populations, fixed designs based only on planning assumptions lost power, whereas the proposed SSR maintained power near the target level and performed similarly to an oracle design. In an illustrative ADCS-based example, the proposed procedures yielded different final sample sizes across adjustment sets, reflecting evolving enrolled-population covariate profiles. These results support covariate-adaptive, outcome-blinded SSR as a practical design strategy for externally controlled single-arm trials that target population-standardized treatment effects.
Two frequent approaches for identifying structural VARs are external instruments, which carry economic content but are often weak, and non-Gaussianity of the shocks, which provides statistical identification but carries no economic meaning. We combine the two strategies in a single generalized method of moments framework. This hybrid approach point-identifies the target shocks while also identifying the non-target shocks up to sign and ordering. Under suitable rank…
逐点 CATE 估计的极小极大速率:设计平滑度的作用
We study the role of design smoothness in the minimax estimation of conditional average treatment effects at a fixed covariate point. For design densities bounded above and away from zero, without further regularity, we derive upper and lower risk bounds with an arbitrarily small gap in the convergence-rate exponent. Under uniform design, we obtain matching upper and lower bounds at interior points in the regime of low nuisance smoothness. These results show that rough…
Bayesian additive regression trees (BART) is a popular Bayesian ensemble model used in regression and classification analysis. Under this modeling framework, the regression function is approximated by an ensemble of decision trees, interpreted as weak learners. In this work, we propose a generalization of the BART model that has two main features: first, it automatically selects the number of decision trees using the given data; second, the model allows clusters of…
估计纵向因果剂量反应关系的贝叶斯框架
Existing causal methods for time-varying exposure and time-varying confounding focus on estimating the average causal effect of a time-varying binary treatment on an end-of-study outcome, offering limited tools for characterizing marginal causal dose-response relationships under continuous exposures. We propose a scalable, nonparametric Bayesian framework for estimating marginal longitudinal causal dose-response functions with repeated outcome measurements. Our approach…
The conditional average treatment effect (CATE) is frequently estimated in clinical studies to refute a homogeneous treatment effect hypothesis. Under this regime, all patients making up the population experience identical benefit from a given treatment relative to a comparator. Uncovering heterogeneous treatment effects through inference about the CATE, however, requires that covariates truly modifying the treatment effect be reliably collected at baseline. CATE-based…
内生性检验:一种基于矩的贝叶斯方法
A standard assumption in the Bayesian estimation of linear regression models is that the regressors are exogenous in the sense that they are uncorrelated with the model error term. In practice, however, this assumption can be invalid. In this article, using the exponentially tilted empirical likelihood (ETEL) framework, we develop a Bayes factor test for endogeneity that compares a base model that is correctly specified under exogeneity but misspecified under endogeneity…